Hosted on MSN
New blood test for Alzheimer's gets FDA clearance
The Food and Drug Administration (FDA) has cleared a new blood test designed to help diagnose Alzheimer’s disease, which is expected to be available later this year. The blood test, known as ...
New Hampshire Union Leader
Lilly Alzheimer's drug gets unanimous backing from FDA advisory panel
Outside advisers to the Food and Drug Administration on Monday voted unanimously that the benefits of Eli Lilly's experimental Alzheimer's treatment donanemab outweighed its risks, and agreed that ...
The American Journal of Managed Care
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
PrecivityAD2 is cleared for adults ≥40 with cognitive impairment symptoms and is intended to complement, not replace, standard diagnostic evaluation incorporating history, exam, cognitive testing, ...
Medical News Today
FDA clears first single-biomarker blood test for Alzheimer’s: 4 experts weigh in
On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...
AOL
FDA clears first single-biomarker blood test for Alzheimer’s: 4 experts weigh in
On August 24, 2026, the U.S. Food & Drug Administration (FDA) cleared the use of a new single-biomarker blood test to help doctors look for signs of Alzheimer’s disease in older adults 55 and older ...